CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 120 filers reported holding CYTOMX THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $76 | -99.6% | 47,723 | +304.4% | 0.02% | +525.0% |
| Q3 2022 | $17,000 | -22.7% | 11,800 | 0.0% | 0.00% | -33.3% |
| Q2 2022 | $22,000 | -65.6% | 11,800 | -50.0% | 0.01% | -25.0% |
| Q1 2022 | $64,000 | -33.3% | 23,600 | +6.4% | 0.01% | -42.9% |
| Q4 2021 | $96,000 | -64.8% | 22,184 | -32.6% | 0.01% | -75.9% |
| Q4 2019 | $273,000 | – | 32,895 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 524,763 | $7,924,000 | 3.84% |
| Congress Park Capital LLC | 123,311 | $1,862,000 | 2.05% |
| Perceptive Advisors | 2,911,715 | $43,588,000 | 1.66% |
| RTW INVESTMENTS, LP | 908,586 | $13,720,000 | 1.28% |
| HAMILTON LANE ADVISORS LLC | 68,753 | $1,038,000 | 0.91% |
| HARBOURVEST PARTNERS LLC | 79,193 | $1,196,000 | 0.57% |
| SPHERA FUNDS MANAGEMENT LTD. | 273,151 | $4,125,000 | 0.46% |
| Exane Asset Management | 50,000 | $755,000,000 | 0.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 622,548 | $9,400,000 | 0.38% |
| Cormorant Asset Management, LP | 296,712 | $4,480,000 | 0.36% |